Finance

Beta
Lists
532834:BOM
Camlin Fine Sciences Ltd
₹135.00
+12.73%
(+15.25) 1D
Jun 5, 3:40:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
₹121.25
High
₹139.65
Low
₹119.25
Mkt. cap
25.91B
Avg. vol.
119.20K
Volume
428.85K
52-wk high
₹334.70
52-wk low
₹96.30
EPS
-₹1.45
Shares outstanding
121.25M
No. of employees
661
Open
₹121.25
High
₹139.65
Low
₹119.25
Mkt. cap
25.91B
Avg. vol.
119.20K
Volume
428.85K
52-wk high
₹334.70
52-wk low
₹96.30
EPS
-₹1.45
Shares outstanding
121.25M
No. of employees
661
News stories
From sources across the web
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees661
Founded1931
Headquarters-
SectorSpeciality chemicals
Websitecamlinfs.com
Last report
May 26, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹0.76 / ₹0.10
+656.10%beat
Revenue / Est. (INR)
4.25B / 4.54B
-6.36%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.24B
4.60B
4.57B
4.25B
Cost of goods sold
2.37B
2.47B
2.48B
2.19B
Cost of revenue
2.37B
2.47B
2.48B
2.19B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
595.70M
602.93M
637.64M
659.31M
Operating expense
1.91B
1.99B
2.04B
2.06B
Total operating expenses
4.28B
4.45B
4.52B
4.24B
Operating income
-40.36M
145.85M
53.04M
3.71M
Other non operating income
85.63M
17.20M
29.36M
52.84M
EBT including unusual items
-42.64M
-923.00K
-278.54M
-52.63M
EBT excluding unusual items
-42.64M
-923.00K
-103.43M
26.86M
Income tax expense
-100.00K
59.12M
452.00K
-62.37M
Effective tax rate
0.23%
-6,405.31%
-0.16%
118.51%
Other operating expenses
1.14B
1.19B
1.23B
1.19B
Net income
-99.61M
-143.84M
-362.30M
882.02M
Net profit margin
-2.35%
-3.13%
-7.92%
20.76%
Earnings per share
-0.53
-0.29
-0.94
0.76
Interest and investment income
-
-
-
-
Interest expense
-149.02M
-152.05M
-183.29M
-188.00M
Net interest expenses
-149.02M
-152.05M
-183.29M
-188.00M
Depreciation and amortization charges
169.20M
188.27M
167.28M
208.15M
EBITDA
109.80M
324.59M
203.20M
188.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer